NCT07342179 2026-02-18
CART I5M
Poitiers University Hospital
Phase NA Recruiting
Clinical Trials
14 trialsNCT02800954 2025-11-19
MCSF-MYELOME
Centre Hospitalier Universitaire, Amiens
Phase NA Completed
NCT06474182 2025-09-25
ProApix
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Recruiting
NCT05259553 2025-04-09
VESICOM
Centre Hospitalier Universitaire de Saint Etienne
Phase NA Recruiting
NCT03508765 2024-03-08
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03371420 2023-04-18
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT04872023 2023-02-03
IMMUNO-MYELO
Rennes University Hospital
Phase NA Completed
NCT04150692 2022-01-24
Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma
Washington University School of Medicine
Phase 2 Withdrawn
NCT03956615 2021-12-01
MUM
Universitair Ziekenhuis Brussel
Phase NA Completed
NCT03665155 2021-07-30
First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00569309 2018-03-12
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT02260414 2017-05-11
METRO B
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Completed
NCT01543100 2014-01-06
PACMoG
Rennes University Hospital
Phase NA Completed